109 related articles for article (PubMed ID: 16038031)
21. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
[TBL] [Abstract][Full Text] [Related]
22. COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.
Honjo S; Osaki M; Ardyanto TD; Hiramatsu T; Maeta N; Ito H
DNA Cell Biol; 2005 Mar; 24(3):141-7. PubMed ID: 15767780
[TBL] [Abstract][Full Text] [Related]
23. Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells.
Shida D; Kitayama J; Yamaguchi H; Yamashita H; Mori K; Watanabe T; Nagawa H
World J Gastroenterol; 2005 Sep; 11(36):5638-43. PubMed ID: 16237757
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
[TBL] [Abstract][Full Text] [Related]
25. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line.
Lee SJ; Hwang JW; Yim H; Yim HJ; Woo SU; Suh SJ; Hyun JJ; Jung SW; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
J Gastroenterol Hepatol; 2014 Jun; 29(6):1299-307. PubMed ID: 24372723
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
Kanda N; Watanabe S
J Invest Dermatol; 2002 Nov; 119(5):1080-9. PubMed ID: 12445196
[TBL] [Abstract][Full Text] [Related]
28. The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells.
Che SM; Zhang XZ; Liu XL; Chen X; Hou L
Dis Esophagus; 2011 May; 24(4):265-73. PubMed ID: 21087344
[TBL] [Abstract][Full Text] [Related]
29. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
Leung E; McArthur D; Morris A; Williams N
Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
[TBL] [Abstract][Full Text] [Related]
31. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases.
Pan MR; Chang HC; Hung WC
Cell Signal; 2008 Jun; 20(6):1134-41. PubMed ID: 18374541
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta1 reverses inhibition of COX-2 with NS398 and increases invasion in prostate cancer cells.
Ding Q; Bai YF; Wang YQ; An RH
Am J Med Sci; 2010 May; 339(5):425-32. PubMed ID: 20375691
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells.
Deng Y; Su Q; Mo J; Fu X; Zhang Y; Lin EH
Cancer Invest; 2013 Feb; 31(2):97-102. PubMed ID: 23245395
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
35. Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2.
Huang DS; Shen KZ; Wei JF; Liang TB; Zheng SS; Xie HY
World J Gastroenterol; 2005 Jan; 11(2):204-7. PubMed ID: 15633216
[TBL] [Abstract][Full Text] [Related]
36. The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.
Munkarah AR; Ali-Fehmi R; Jiang JZ; Elhammady E; Malone JM; Saed GM
Anticancer Drugs; 2007 Sep; 18(8):889-96. PubMed ID: 17667594
[TBL] [Abstract][Full Text] [Related]
37. NS398 protects cells from sodium nitroprusside-mediated cytotoxicity through enhancing HO-1 induction independent of COX-2 inhibition.
Nizamutdinova IT; Lee JH; Seo HG; Chang KC; Kim HJ
Arch Pharm Res; 2009 Jan; 32(1):99-107. PubMed ID: 19183882
[TBL] [Abstract][Full Text] [Related]
38. [Effect of COX-2 inhibitor on the expression of BCL-3 and cyclin D1 in human colon cancer cell line SW480].
Wang SM; Ye M; Ni SM; Wu X; Yang G
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Aug; 13(8):612-5. PubMed ID: 20737317
[TBL] [Abstract][Full Text] [Related]
39. [Nonsteroidal anti-inflammatory drug NS398 induces RECK expression in the animal model of prostate cancer].
Xu ZY; Gao JP; Sun YH; Zhang ZY; Ge JP; Xu CL; Wang LH
Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1079-82. PubMed ID: 21348197
[TBL] [Abstract][Full Text] [Related]
40. COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals.
Han S; Roman J
Lung Cancer; 2006 Mar; 51(3):283-96. PubMed ID: 16376453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
